Target intelligence / Profile preview

G protein-activated inwardly rectifying potassium channel (GIRK)

Target
GIRK
Molecular classification
Ion channel, Inwardly rectifying potassium channel, Kir family
01

Overview

The G protein-activated inwardly rectifying potassium (GIRK) channel, frequently referred to in medical and pharmacological texts as the 'calcium-dependent inwardly rectifying potassium channel' [2, 3, 7, 12], is a class of ion channels (Kir3 subfamily) primarily expressed in the central nervous system and the heart [1, 13, 14]. These channels are crucial for the inhibitory control of neuronal excitability and the regulation of heart rate. Unlike most potassium channels that are voltage-gated, GIRK channels are directly activated by the Gβγ subunits of G proteins, which are released following the stimulation of Gi/o-coupled receptors such as mu-opioid, GABA-B, and muscarinic M2 receptors [5, 12, 14]. Upon activation, the channel permits the efflux of potassium ions, causing membrane hyperpolarization and effectively suppressing neuronal firing and neurotransmitter release [3, 7, 12]. This mechanism is central to the action of opioid analgesics, which exert their effects by opening GIRK channels in the pain-processing pathways of the spinal cord and brain [2, 3, 5, 12]. Because they play a pivotal role in the 'braking' system of the nervous system, GIRK channels are implicated in a wide array of conditions, including chronic pain, epilepsy, drug addiction, and psychiatric disorders like schizophrenia [11, 14, 15]. In the cardiovascular system, GIRK activation in the atria contributes to the slowing of the heart rate mediated by the parasympathetic nervous system [1, 13, 14]. Therapeutic modulation of these channels offers opportunities for treating neurological and cardiac diseases, although safety concerns such as respiratory depression and cardiac slowing remain significant challenges [12, 14].

Other names
Calcium-dependent inwardly rectifying potassium channelG protein-coupled inwardly rectifying potassium channelKir3 channelG-protein gated inwardly rectifying potassium channelInwardly rectifying potassium channel 3
02

Mechanism of action

Binding of agonists to Gi/o-coupled receptors, such as the mu-opioid receptor, triggers the dissociation of heterotrimeric G-proteins; the released Gβγ subunits then bind directly to the GIRK channel, increasing its open probability and potassium conductance, which induces membrane hyperpolarization and suppresses cellular excitability [2, 6, 12].

03

Biological functions

Neuronal hyperpolarizationInhibition of neurotransmitter releaseRegulation of resting membrane potentialCardiac rate controlSignal transduction
04

Disease associations

PainDrug addictionEpilepsyCardiac arrhythmiaParkinson's diseaseSchizophrenia
05

Safety considerations

Respiratory depressionBradycardiaSedationPhysical dependence and withdrawalDrug tolerance
06

Interacting drugs

Morphine

8 more in the full profile.

07

Biomarkers

Respiratory rate (monitoring for agonist efficacy and toxicity)Pupil diameter (miosis as a marker of opioid-induced GIRK activation)QT interval (monitored during drug interactions or with specific channel variants)

Beyond the preview

Go deeper on G protein-activated inwardly rectifying potassium channel (GIRK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-activated inwardly rectifying potassium channel (GIRK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call